Compared to wild-type C-ABL1, BCR/ABL1 fusion protein displays increased kinase activity, which makes it a necessary and sufficient initiating trigger in CML [3]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.